Sugi Predict

Sugi Predict / Compounds / SCHEMBL29412270

SCHEMBL29412270

SCHEMBL29412270

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1cnc[nH]1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)O)C(C)C)[C@@H](C)CC

nearest known ligand 0.66

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ VIPR2 P41587 7/20 0.66
▸ VIPR1 P32241 5/20 0.65
▸ PTH1R Q03431 3/20 0.63
▸ GLP1R P43220 9/20 0.61
▸ ECE1 P42892 1/20 0.61
▸ MUS81 Q96NY9 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29587816 0.98 VIPR2 (0.63) VIPR2VIPR1PTH1RGLP1RECE1
Magainin 2 SCHEMBL29374652 0.91 PTH1R (0.66) VIPR1PTH1RGLP1R
SCHEMBL29401001 0.89 PTH1R (0.68) VIPR1PTH1RGLP1R
SCHEMBL30711673 0.89 PTH1R (0.68) VIPR1PTH1RGLP1R
SCHEMBL31332217 0.89 PTH1R (0.66) VIPR1PTH1RGLP1R
SCHEMBL29389123 0.88 PTH1R (0.63) VIPR2VIPR1PTH1RGLP1RECE1
SCHEMBL30633102 0.87 PTH1R (0.61) VIPR1PTH1RGLP1RECE1MUS81
SCHEMBL29352003 0.87 CCNA2 (0.57) VIPR2VIPR1PTH1R
SCHEMBL4329513 0.86 VIPR1 (0.78) VIPR2VIPR1PTH1RGLP1RECE1
SCHEMBL29623290 0.86 VIPR2 (0.65) VIPR2VIPR1GLP1RECE1MUS81

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3129044-B1 PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS LYSANDO AG (LI) 2022-09-07 — — EP claimed
US-12371459-B2 Antimicrobial peptide derived from Pseudin-2 peptide and uses thereof INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2025-07-29 — — US disclosed
US-20250185669-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2025-06-12 — — US disclosed
US-12232498-B2 Anti-viral paints and coatings and articles comprising same Reactive Surfaces Ltd., LLP (US) 2025-02-25 — — US disclosed
US-20240172762-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2024-05-30 — — US disclosed
US-11980192-B2 Anti-viral paints and coatings and articles comprising same Reactive Surfaces Ltd., LLP (US) 2024-05-14 — — US disclosed
US-11958890-B2 Antimicrobial proteins LYSANDO AG (LI) 2024-04-16 — — US disclosed
US-20240016160-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2024-01-18 — — US disclosed
US-11866750-B2 Endolysin variant SASINAPAS CO., LTD. (TH) 2024-01-09 — — US disclosed
US-11832616-B2 Anti-viral paints and coatings and articles comprising same Reactive Surfaces Ltd., LLP (US) 2023-12-05 — — US disclosed
US-20230270118-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2023-08-31 — — US disclosed
US-11690899-B2 Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection Micreos Human Health B.V. (NL) 2023-07-04 — — US disclosed
EP-3129044-B1 PEPTIDOGLYCAN HYDROLASE FOR USE IN THE TREATMENT OF CHRONIC BACTERIAL INFECTIONS LYSANDO AG (LI) 2022-09-07 — — EP disclosed
US-11427812-B2 Antimicrobial agents against Staphylococcus aureus LYSANDO AG (LI) 2022-08-30 — — US disclosed
US-20220153789-A1 NOVEL ANTIMICROBIAL PEPTIDE DERIVED FROM PSEUDIN-2 PEPTIDE AND USES THEREOF INDUSTRY-ACADEMIC COOPERATION FOUNDATION, CHOSUN UNIVERSITY (KR) 2022-05-19 — — US disclosed
US-11304420-B2 Anti-viral paints and coatings and articles comprising same Reactive Surfaces Ltd., LLP (US) 2022-04-19 — — US disclosed
EP-3978605-A1 ANTIMICROBIAL AGENTS AGAINST SALMONELLA BACTERIA Lysando AG (LI) 2022-04-06 — — EP disclosed
US-20220087267-A1 ANTI-VIRAL PAINTS AND COATINGS AND ARTICLES COMPRISING SAME Reactive Surfaces Ltd., LLP (US) 2022-03-24 — — US disclosed
EP-3541406-B1 NEW ANTIMICROBIAL AGENTS AGAINST STAPHYLOCOCCUS AUREUS LYSANDO AG (LI) 2022-03-16 — — EP disclosed
US-20220064623-A1 ENDOLYSIN VARIANT SASINAPAS CO., LTD. (TH) 2022-03-03 — — US disclosed
Send feedback